Skip Navigation



Journal of Public Health Advance Access published online on October 28, 2009

Journal of Public Health, doi:10.1093/pubmed/fdp092
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Horgan, J.M.P.
Right arrow Articles by McManus, R.J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horgan, J.M.P.
Right arrow Articles by McManus, R.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009, Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved

Evaluation of a cardiovascular disease opportunistic risk assessment pilot (‘Heart MOT’ service) in community pharmacies


J.M.P. Horgan
, Head of Medicines Management1
A. Blenkinsopp
, Professor of the Practice of Pharmacy2
R.J. McManus
, Professor of Primary Care Cardiovascular Research3

1 NHS South Birmingham, Trust Headquarters, Moseley Hall Hospital, Alcester Road, Moseley, Birmingham B13 8JL, UK
2 Medicines Management, Keele University, Staffordshire ST5 5BG, UK
3 Primary Care Clinical Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK


Address correspondence to Jonathan Horgan, E-mail: jonathan.horgan{at}sbpct.nhs.uk


   Abstract

Background Cardiovascular risk-based screening is proposed as a key intervention to reduce premature cardiovascular disease (CVD) in the UK and internationally. This study evaluated a targeted cardiovascular (CVD) assessment pilot in 23 community pharmacies in Birmingham, UK.

Methods The CVD risk assessment service used near-patient testing and the Framingham risk equations administered by pharmacists to screen clients aged 40–70 without known CVD. Outcomes assessed included volume of activity, uptake by deprivation and ethnicity and onwards referral.

Results Complete data were available for 1130 of 1141 clients; 679 (60%) male, 218 (19%) smokers and 124 (11%) had a family history of CVD. Overall, 792 (70%) of clients were referred to their general practice: 201 (18%) at CVD risk of 20% or more, remainder with individual risk factor(s). Greater representation from Black (7.4%) and Asian (24.8%) communities and from average and less deprived quintiles than the affluent and most deprived was observed.

Conclusions Community pharmacies can provide a CVD risk assessment service in a UK urban setting that can attract males and provide access for deprived communities and Black and Asian communities. A pharmacy service can support GP practices in identifying and managing the workload of around 30% of clients.

Keywords: circulatory disease, health services, screening


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.